AstraZeneca Pharma India Limited reports a change in its board or management
In short
AstraZeneca Pharma India Limited informed the NSE on August 22, 2026, that a director, KMP or SMP has resigned. No figures or breakdowns were given. In simple terms, the company told the exchange that one of its senior officials has stepped down, which means a change in its leadership. No closing date or validity period was stated.
Why it matters
A change at the leadership or audit level — worth checking who's departing/joining and whether the filing gives a reason. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.